• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Citius Pharmaceuticals, Inc. - Common Stock (NQ:CTXR)

    0.9011 -0.0299 (-3.21%)
    Streaming Delayed Price Updated: 1:00 PM EDT, Mar 11, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Citius Pharmaceuticals, Inc. - Common Stock

    Citius Pharmaceuticals (NASDAQ: CTXR) Eyes $400M Market Opportunity with LYMPHIR Launch
    Via AB Newswire
    Topics Economy
    News headline image
    Biotech Stocks Race Towards Solutions for Cutaneous T-Cell Lymphoma (CTCL)
    Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - July 18, 2024) - Investorideas.com, a go-to investing platform releases the second... 
    Via Newsfile
    News headline image
    Analysts Hunt for Undervalued Biotech Stocks
    Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - July 17, 2024) - Investorideas.com, a go-to investing platform releases the first... 
    Via Newsfile
    Topics Economy Initial Public Offering
    Citius Pharmaceuticals (CTXR) Eyes Breakthrough with Late-Stage Drug Pipeline Poised for Regulatory Approval
    Via AB Newswire
    Citius Pharmaceuticals (NASDAQ: CTXR) Spearheads the Global Cancer Immunotherapy Market
    Via Get News
    News headline image
    Bloodstream Infections - From Threats to Solutions
    Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - July 11, 2024) - Investorideas.com, a go-to investing platform releases the second... 
    Via Newsfile
    Topics Death
    Citius Pharmaceuticals (CTXR) Nears Key FDA Decisions and Launch Plans for 2024
    Via AB Newswire
    News headline image
    Biopharma Stocks Transformative Innovation for the Future of Health
    Vancouver, Kelowna and Delta, British Columbia--(Newsfile Corp. - July 11, 2024) - Investorideas.com, a go-to investing platform releases the first... 
    Via Newsfile
    Topics Artificial Intelligence
    Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) Featured in Coverage of the EF Hutton Annual Global Conference
    Via Investor Brand Network
    News headline image
    Sidoti Events, LLC’s Virtual November Micro-Cap Conference
    Via ACCESSWIRE
    Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) is Specializing in Stem Cell Therapy & Critical Cancer Care Immunotherapy
    Via Get News
    Citius Pharmaceuticals, Inc is helping Global Cancer Immunotherapy to reach the Market Cap of 152 Billion by 2024.
    Via AB Newswire
    Biotechs Zero in on Growing Ovarian Cancer Market as Pivotal Trials Advance Through Regulatory Agencies
    Via FinancialNewsMedia
    Topics Death
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.